5066 Nab-paclitaxel weekly or Q3w compared to docetaxel Q3w as first-line therapy in patients with metastatic breast cancer (MBC): an economic analysis of a prospective randomized trial from the perspective of the German health care system

✍ Scribed by G. Dranitsaris; T. Schöning

• Book ID: 119600716
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 50 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(09)70958-9